D630045J12Rik Inhibitors
D630045J12Rik, a gene located in the photoreceptor connecting cilium, exhibits a broad expression pattern in tissues such as the central nervous system, retina, dorsal root ganglion, tooth, and trachea cartilaginous ring. Despite its wide distribution, the precise function of D630045J12Rik remains largely unknown, emphasizing the complexity of its role in various physiological processes. Implicated in retinitis pigmentosa 86, a hereditary disorder leading to progressive vision loss, D630045J12Rik likely contributes to the maintenance of photoreceptor integrity and function. The inhibition of D630045J12Rik involves a diverse set of mechanisms targeting various aspects of cellular regulation. Epigenetic modifiers, such as histone deacetylase inhibitors and DNA methyltransferase inhibitors, impact chromatin structure and DNA methylation patterns, respectively. This suggests a regulatory role for D630045J12Rik that involves the modification of its expression through epigenetic mechanisms. Additionally, inhibitors targeting key signaling pathways, including the MAPK, PI3K/AKT, TGF-β, and JNK pathways, underscore the gene's involvement in intricate cellular cascades. These pathways play crucial roles in cellular processes within structures like the dorsal root ganglion and retina, shedding light on potential regulatory networks governed by D630045J12Rik.
The gene's location in the photoreceptor connecting cilium, along with its association with retinitis pigmentosa, implies a specific role in maintaining retinal health and function. The inhibition strategies, collectively, reflect a concerted effort to unravel the gene's intricate regulatory mechanisms and understand its contribution to retinal diseases. The diversity of inhibitors employed, targeting both epigenetic modifications and signaling pathways, highlights the multifaceted nature of D630045J12Rik's involvement in cellular processes. Continued research into the gene's function and the development of refined inhibition strategies will contribute to a more comprehensive understanding of its role in health and disease.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, impacting chromatin structure and gene expression. Vorinostat modulates epigenetic regulation, potentially affecting D630045J12Rik transcription in the retina and central nervous system. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor altering DNA methylation patterns. Decitabine may impact the epigenetic landscape, influencing D630045J12Rik expression and regulation in photoreceptor connecting cilium and central nervous system tissues. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of TGF-β receptor kinase, affecting the TGF-β signaling pathway. SB431542's impact on this pathway could potentially modulate D630045J12Rik expression, especially in structures like the retina and trachea cartilaginous ring, implicated in retinitis pigmentosa 86. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitor disrupting BET protein function. JQ1 may influence chromatin structure and gene expression, potentially affecting D630045J12Rik expression in photoreceptor connecting cilium and various structures in the central nervous system. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor disrupting the PI3K/AKT pathway. LY294002's impact on this signaling cascade may modulate D630045J12Rik expression in tissues such as the dorsal root ganglion and retina, altering cellular processes associated with retinitis pigmentosa 86. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Broad-spectrum histone deacetylase inhibitor. Trichostatin A influences chromatin structure and gene expression, potentially impacting D630045J12Rik transcription in structures like the retina and central nervous system. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK signaling pathway. SP600125's modulation of this pathway may influence D630045J12Rik expression, particularly in tissues such as the dorsal root ganglion and retina, potentially associated with retinitis pigmentosa 86. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor altering DNA methylation patterns. 5-Azacytidine's impact on the epigenetic landscape may influence D630045J12Rik expression and regulation in photoreceptor connecting cilium and central nervous system tissues. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor affecting the p38 MAPK signaling pathway. SB203580's modulation of this pathway may impact D630045J12Rik expression, especially in structures like the dorsal root ganglion and retina, potentially associated with retinitis pigmentosa 86. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $151.00 $461.00 | 1 | |
EZH2 inhibitor affecting the PRC2 complex. GSK343's impact on epigenetic regulation may influence D630045J12Rik expression in various structures, including the retina and central nervous system, potentially associated with retinitis pigmentosa 86. | ||||||